ArticleSignal transduction and targeted therapy2025

Glibenclamide targets MDH2 to relieve aging phenotypes through metabolism-regulated epigenetic modification.

Zhifan Mao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.